About OCEANA | Products | Business Development | Investor Relations | Media Room

 


Business Development

Today's pharmaceutical licensing environment is extremely competitive. Specialty Pharma Companies must be able to move quickly to identify, evaluate, and negotiate deals that create shareholder value. Oceana Therapeutics executives have an edge over the competition by actively pursuing a strategy of identifying, acquiring and maximizing the potential of approved and late-stage development pharmaceuticals without having to go through layers of upper management. Licensing and acquisition negotiations are carried out with the highest regard for fairness and speed.

Oceana Therapeutics managers are leading, seasoned professionals in pharmaceutical and biotech business development who have executed over $500 million in-licensing deals and charted new acquisition strategies in specialty pharma business development.

Oceana Therapeutics is currently evaluating several approved and late stage development specialty pharmaceuticals and are focusing their product search areas in pediatric endocrinology, urology, gastroenterology, endocrinology, cardiology and acute care. Their product acquisition methodology includes:

Optimal Identification

Oceana Therapeutics brings together a team of individuals with Extensive Background and Experience in acquiring, developing and commercializing pharmaceuticals.

  • Identify licensing/acquisition opportunities that meet targeted strategic criteria of both a viable wellness alternative and enables better physician care management
  • Conduct licensing/acquisition opportunity screening and validate candidates through market research and segmentation

Optimal Acquisition

Oceana Therapeutics' management team is credited with leading Product and Technology Development with numerous New Drug Approvals, EU/Worldwide approvals over 20 licensing deals as well as having built and managed cGMP manufacturing operations.

  • Optimize the potential commercial value of licensing/acquisition opportunities through their proprietary distribution network which includes physicians, healthcare facilities and specialty wholesalers.
  • Apply advanced analytical, promotion and distribution approaches to enhance financial viability of licensed/acquired drugs.
  • Gain FDA approvals if needed

Optimal Maximization

Our Sales and Marketing expertise is proven by an excellent history of commercializing pharmaceutical products.

  • Develop or improve drug marketing strategy, advertising and promotional pieces
  • Develop or enhance sales channels for distribution by diminishing the provider issues normally associated with new drug delivery
  • Identify potential sales and licensing partners
  • Long and distinguished history of hiring, developing and training specialty sales forces as well as designing sales territories for optimal efficiency.

Contact:
bisdev@oceanathera.com

 

Adverse Event | Contact | Work@OCEANA | Privacy | Terms of use | Code of Conduct | Site Map

©2009 OCEANA Therapeutics, Inc.